LSTA
LISATA THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$1.00
−2.91%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$1.13
- Revenue estimate
- $659.0K
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.32
- EPS estimate
- —
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +14.4%
- Revenue beats (12Q)
- —
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | — | -$0.32 | — | — |
| May 11, 2026 | — | -$0.50 | — | — |
| Mar 12, 2026 | -$0.51 | -$0.33 | Beat 35.29% | $100.0K |
| Nov 6, 2025 | -$0.54 | -$0.49 | Beat 9.26% | — |
| Aug 7, 2025 | -$0.65 | -$0.54 | Beat 16.92% | $70.0K |
| May 8, 2025 | -$0.53 | -$0.55 | Miss -3.77% | — |
| Feb 27, 2025 | -$0.76 | -$0.55 | Beat 27.63% | $1.0M |
| May 9, 2024 | -$0.73 | -$0.65 | Beat 10.96% | — |
| Feb 29, 2024 | -$0.86 | -$0.66 | Beat 23.26% | — |
| Nov 2, 2023 | -$0.93 | -$0.65 | Beat 30.11% | — |
| Aug 14, 2023 | -$0.70 | -$0.50 | Beat 28.57% | — |
| Nov 10, 2022 | -$0.90 | -$1.47 | Miss -63.33% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026